Welcome to our dedicated page for Cineverse SEC filings (Ticker: CNVS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cineverse Corp. (NASDAQ: CNVS) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, allowing investors to review how this next-generation entertainment studio reports on its film, streaming, and technology operations. Cineverse files periodic reports, proxy statements, and current reports that together outline its financial performance, governance practices, and material corporate events.
Among the key documents, Form 10-K annual reports and Form 10-Q quarterly reports (referenced in earnings-related 8-Ks) describe Cineverse’s revenue from streaming and digital distribution, base distribution, and content licensing, as well as information about its large content library and technology platforms such as Matchpoint™, CINESEARCH, cineCore, and C360. These filings also discuss risks, business strategy, and segment performance across its entertainment and technology activities.
Form 8-K current reports provide timely details on specific events. Recent examples include an 8-K describing an amendment to the 2017 Equity Incentive Plan approved at the November 20, 2025 annual meeting, and another 8-K outlining an employment agreement with the company’s Chief Financial Officer, including compensation and change-in-control provisions. Additional 8-Ks reference the release of quarterly and annual financial results via press releases.
The DEF 14A definitive proxy statement offers insight into Cineverse’s corporate governance, director elections, advisory votes on executive compensation, equity plan amendments, and auditor ratification. It also explains how stockholders can participate in the virtual annual meeting and vote on key proposals.
On Stock Titan, Cineverse filings are supplemented with AI-powered summaries that help explain complex sections of 10-Ks, 10-Qs, and proxies in plain language. Real-time updates from EDGAR ensure that new 8-Ks, equity plan changes, and other disclosures appear promptly, while insider-related filings such as Form 4 (when available) can be used to monitor transactions in Cineverse equity by officers and directors.
Together, these SEC documents provide a structured view of how Cineverse manages its capital, compensates executives, and reports on the progress of its entertainment and media technology businesses.
Cineverse Corp. (CNVS) filed Amendment No. 2 to its 2025 proxy, updating Proposal Four language about the 2017 Equity Incentive Plan. The plan now states a $1,000,000 annual cap on the aggregate value of Common Stock issuable to all non-employee directors. It also clarifies that each non-employee director is anticipated to receive a $90,000 restricted stock award after each annual meeting, valued using the trailing 20-day VWAP as of the meeting date, whether or not the proposal is approved.
Cineverse Corp. (CNVS) filed definitive additional proxy materials tied to its 2025 annual meeting set for November 20, 2025. The filing states it was made solely to include required interactive data; all other proxy details remain unchanged.
Stockholders will vote on electing four directors, an advisory say‑on‑pay, the frequency of future say‑on‑pay (the Board recommends 1 year), an amendment to the 2017 Equity Incentive Plan to increase authorized shares from 2,504,913 to 3,504,913, and ratification of EisnerAmper LLP as auditor for the year ending March 31, 2026.
Holders of record on September 24, 2025 may vote. 19,124,406 shares of Class A Common Stock were outstanding as of that date. The proxy outlines plan governance features (no evergreen, no repricing without stockholder approval, minimum one‑year vesting, clawback) and indicates non‑employee director equity awards valued at $90,000 annually (based on 20‑day VWAP) and $180,000 for new directors. CNVS last closed at $3.50 on September 24, 2025.
Mark W. Lindsey, Chief Financial Officer of Cineverse Corp. (CNVS) reported changes in his holdings on
The disclosure itemizes vesting timelines: portions of RSUs vest in
Insider transfer reported by Cineverse Corp. officer Yolanda Macias. The filing shows Ms. Macias holds 93,949 Class A shares indirectly and reports a disposition of 93,949 Class A shares plus an indirect 146 share holding for a minor child. She also holds multiple equity awards: two stock appreciation rights covering 30,000 and 25,000 shares with exercise prices of
Christopher J. McGurk, CEO and Chairman of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on
Insider transaction summary for Cineverse Corp. (CNVS): The reporting officer, Mark Antonio Huidor, reported a disposal and several derivative/award holdings. On
Cineverse Corp. (CNVS) reported an insider equity award on a Form 4. The company’s Chief People Officer received 66,763 restricted stock units (RSUs) on 10/08/2025 (transaction code A, price $0). These RSUs vest in three equal-year tranches: 22,254 on October 8, 2026, 22,254 on October 8, 2027, and 22,255 on October 8, 2028.
Following the reported transactions, the officer beneficially owned 158,274 shares of Class A common stock directly. Derivative holdings include stock appreciation rights for 8,334 shares (exercise price $39.4, expiring 02/17/2031) and 12,500 shares (exercise price $5.8, expiring 05/16/2033), plus other RSUs of 66,667 and 76,820 with stated vesting schedules.
Erick Opeka, CSO and President of Cineverse Corp. (CNVS), reported multiple equity changes on
Gary S. Loffredo, Chief Legal Officer, Secretary and Senior Advisor at Cineverse Corp. (CNVS), filed a Form 4 reporting multiple equity changes on
Cineverse Corp. outlines its 2017 Equity Incentive Plan governance and 2023–2025 executive and director compensation practices. The plan is administered by an independent Compensation Committee, has no evergreen replenishment, and caps aggregate director awards at 300,000 shares. Awards generally carry a minimum one-year vesting requirement (with a 5% exception), prohibit discounted options or repricings without stockholder approval, and are subject to the company's clawback policy.
Reported grants include 237,500 restricted stock awards and 237,500 restricted stock units to NEOs in fiscal 2025 (accounting for $1,501,000 of NEO CAP), and 150,000 restricted awards and 150,000 restricted units to the PEO in fiscal 2025 (accounting for $948,000 of the PEO CAP). Prior-year grants included 115,000 options in 2024 and 125,000 options in 2023 with multi-year vesting and ten-year option terms where noted. Non-employee director pay includes a $60,000 cash retainer, a $90,000 annual stock grant (trailing 20-day VWAP), committee fees, a $20,000 lead director fee, and a $180,000 new-director grant vesting over three years.